Raising Money for your Startup & Storytelling as a Funding StrategyDecember 15, 2020
Raising Money for your Startup & Storytelling as a Funding Strategy
Sarah Larson, Chief People Officer, Section 32 Venture Capital Fund; Andrea Nye, CEO, President &Director of Xylyx Bio; Dr. Milica Radisic, CEO and co-founder Quthero Inc.; Cliff Emmons, Boston Harbor Angel Investor, CEO at IIoT-Oxys
Are you raising money or preparing to? Do you have a fundraising strategy that communicates your story over the key inflection points investors are looking for?
Competition to raise capital is fierce. Our esteemed panel from leading Angel/VC investors and top entrepreneurs successful in raising funds will share success perspectives and tips to help you craft your fundraising story.
5:30 – 6:45 – Networking on Grapevine Network
7:00 – 7:10 PM – ENET Chairperson’s announcements
7:10 – 7:25 PM – eMinute Pitch – Up to 3 Startup companies’ presentations
7:25 – 8:10 PM – expert speakers on the night’s topic
8:10 – 8:30 PM – Moderator and Audience Q & A with the speakers
8:30 – 9:00 PM – Networking on Grapevine Network
(all times are USA Eastern Daylight time)
A question and answer session will follow the panel discussion, and panelists will be available afterward for responses to individual questions.
Sarah Larson, Chief People Officer, Section 32 Venture Capital Fund www.section32.com
Sarah is Section 32’s Chief People Officer and focuses on the firm’s people strategies, ensuring our team can do their most creative and impactful work, and serves as an advisor to the firm’s portfolio of companies.
Prior to joining Section 32, Sarah was Partner and CHRO at Third Rock Ventures where she was responsible for internal human resources and provided guidance and counsel to the portfolio companies, focusing on human capital, talent acquisition and management, leadership development, organizational change and evolution, culture creation, board management, and compensation strategy.
She has served as interim CHRO for Cedilla Therapeutics, Thrive Earlier Detection, Relay Therapeutics, and MOMA Therapeutics and served on the Board of Directors for Thrive Earlier Detection and chaired the Compensation Committee.
Prior to Third Rock, Sarah was SVP, Human Resources at Foundation Medicine, where she worked closely with Mike and Steve. Joining the company at launch, Sarah built and fostered the high-performing culture that made FMI a repeated top place to work and a pioneer for talent branding in the life sciences sector.
Andrea Nye, CEO, President &Director of Xylyx Bio www.xylyxbio.com
Andrea is CEO, President & Director of Xylyx Bio, a commercial-stage biopharma company developing next-generation regenerative solutions to combat fibrosis, scarring, and other conditions involving extracellular matrix.
She is responsible for the overall management, corporate development and strategic planning, and has deep knowledge of the biomedical innovation and entrepreneurship sectors, with extensive experience vetting and supporting early stage ventures working to bring med tech products to market.
Prior to Xylyx, Andrea was Director of Biomedical Innovation Initiatives in the Columbia University Department of Biomedical Engineering, where she oversaw the full life cycle of the Columbia Biomedical Technology Accelerator (Columbia BiomedX), established to facilitate commercialization of clinical solutions through the provision of funding, education and resources to technical teams working to develop and de-risk early-stage biomedical technologies.
Andrea has an MBA and MPH, both from Columbia University, and a BA in Biology and Anthropology and a minor in Chemistry from Western Washington University.
Dr. Milica Radisic, CEO and co-founder Quthero Inc. www.qutheroskincare.com
Dr. Milica Radisic is a CEO and co-founder of Quthero Inc, a company focused on disrupting the way we treat skin after dermatological and surgical procedures.
She is also a co-founder of TARA Biosystems, an award-winning heart-on-a-chip company that uses Dr. Radisic’s mature heart tissue platform in disease modelling and drug testing.
Dr. Radisic also contributes as a Professor at the University of Toronto, Canada Research Chair and a Senior Scientist at the Toronto General Research Institute.
She is recognized as Fellow of the Royal Society of Canada-Academy of Science, Canadian Academy of Engineering, AIMBE and TERMIS. Her scientific work has resulted in over 260 publication with ~14000 citations and an h-index of 61.
Cliff Emmons, Boston Harbor Angel Investor, CEO at IIoT-Oxys
Cliff is an active member of Boston Harbor Angels, a group of proven business leaders interested in investing a portion of our assets in high-growth, early-stage companies. Since 2004, our portfolio has included companies in information technology, life sciences, consumer products, business products, services, specialty materials, aviation and more. We believe we contribute more than just money to the companies we fund. We welcome the opportunity to work with entrepreneurs who are open to taking advice, yet have the smarts and determination to make their company successful.
He is also CEO of IIoT-Oxys, a company at the intersection of IIoT, AI/ ML, and Healthcare Operations, to enable Pharma, Biotech, and Medical Device manufacturing organizations in gaining actionable insights from their operations-generated data.
Cliff is a passionate visionary executive leader with extensive prior experience at Medtronic in creating, building, and transforming businesses in the USA, India, and China. He has led organizations with over 200 employees and multi-million USD budgets.
Moderator and Co-Organizer:
Kristin King, MBA. Vice President, Corporate Development & Strategy, Defibtech, LLC
Kristin is an accomplished MedTech executive, serial intrapreneur, investor and strategic advisor to startups developing biotech solutions.
With over 20 years spanning technical, marketing, and proud member of Boston Harbor Angels, she offers multi-discipline expertise transforming technologies from early concept to successful global divisions at leading Medical Device companies and startups.
She is recognized for strategic development, business acumen, and her ability to build and lead talented teams to commercialize products that change patients’ lives. Starting her career designing stents, a patent inventor for Johnson & Johnson’s drug eluting stent and progressing through global commercial leadership roles, she has contributed to some of the world’s most meaningful programs at top healthcare firms including Ansell Healthcare, Becton Dickinson, Johnson & Johnson Cordis, Abbott Vascular, and Pfizer. Kristin holds a B.S. in bioengineering from Syracuse University, MBA in Finance & Marketing from NYU Stern. Outside of the office she is an avid scuba diver and volunteer for environmental organizations Beneath the Sea and Boston Sea Rovers.
Dave Hall, Founder & CEO , DLH Technology, Advisors Startup Strategy & Venture Capital Consulting
Dave is Founder and CEO of DLH Technogy. He is a startup & strategy Executive, Innovation Consultant, Advisor, Connector, Evangelist and Speaker for growth companies looking to implement, optimize, and fund their Go-to-Market plan.
DLH Technology Advisors offers consulting services including Startup Strategy, Product Development, Startup Frameworks, Business Development, Startup Marketing, Go-to-Market Strategy, Executive Coaching and Startup Funding Channels. DLH has resources for CRM development services including Salesforce implementation, AppExchange App Development, QuickStarts, Lead Architect and Admin Services for the entire Salesforce product line – www.DLHsales.com